Group One Trading
DNA icon

Group One Trading’s Ginkgo Bioworks DNA Stock Holding History

Group One Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.3K Sell
11,800
-69,300
-85% -$576K ﹤0.01% 4988
2025
Q4 		$674K Buy
81,100
+700
+0.9% +$7.54K ﹤0.01% 3229
2025
Q3 		$1.17M Sell
80,400
-85,800
-52% -$1.03M ﹤0.01% 2863
2025
Q2 		$1.87M Buy
166,200
+77,500
+87% +$600K ﹤0.01% 2202
2025
Q1 		$506K Sell
88,700
-231,300
-72% -$2.36M ﹤0.01% 3072
2024
Q4 		$3.14M Sell
320,000
-82,400
-20% -$706K 0.01% 1519
2024
Q3 		$3.28M Buy
402,400
+384,247
+2,117% +$3.85M 0.01% 1347
2024
Q2 		$243K Buy
18,153
+9,578
+112% +$286K ﹤0.01% 3239
2024
Q1 		$398K Sell
8,575
-9,285
-52% -$481K ﹤0.01% 2954
2023
Q4 		$1.21M Sell
17,860
-11,000
-38% -$674K ﹤0.01% 2295
2023
Q3 		$2.09M Buy
28,860
+6,670
+30% +$533K 0.01% 1610
2023
Q2 		$1.65M Buy
22,190
+8,430
+61% +$499K 0.01% 1894
2023
Q1 		$732K Sell
13,760
-16,280
-54% -$1.03M ﹤0.01% 2404
2022
Q4 		$2.03M Sell
30,040
-23,298
-44% -$2.14M ﹤0.01% 1802
2022
Q3 		$6.66M Buy
53,338
+17,948
+51% +$2.14M 0.01% 966
2022
Q2 		$3.37M Buy
35,390
+6,050
+21% +$738K 0.01% 1592
2022
Q1 		$4.73M Sell
29,340
-25,633
-47% -$4.99M ﹤0.01% 1589
2021
Q4 		$18.3M Buy
54,973
+33,753
+159% +$16M 0.01% 727
2021
Q3 		$9.84M Buy
+21,220
New +$10.3M 0.01% 1072

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's DNA Position: Q1 2026 in Review

Group One Trading reduced its Ginkgo Bioworks (DNA) stake by 58% in Q1 2026, selling an estimated $70.2K and leaving 6,017 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5498.

Group One Trading first reported a position in DNA in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.07M in Q1 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Group One Trading held 6,017 shares of Ginkgo Bioworks worth $36.9K as of Q1 2026.
  • Group One Trading sold 8,442 Ginkgo Bioworks shares in Q1 2026, an estimated $70.2K.
  • Ginkgo Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5498 holding.
  • Group One Trading first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 13 quarters since.
  • Group One Trading's Ginkgo Bioworks position peaked at $1.07M in Q1 2024.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.